20 participants
Merck IIT: RRP Pembro and Lenvatinib
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-02
- Start Date:
- 2025-07-18
- Completion:
- 2027-12-31
Conditions
- Human Papilloma Virus
- Recurrent Respiratory Papillomatosis
- Pulmonary Disease
Interventions
- DRUG
No Results Yet